Texas Instruments (TXN) Declares $0.90 Quarterly Dividend; 3.3% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
SK Hynix warns of volatile chip demand after first-quarter profit beats forecast
April 22, 2020 7:51 PM EDTBy Hyunjoo Jin and Heekyong Yang
SEOUL (Reuters) - SK Hynix warned on Thursday that demand for chips will remain volatile, while restrictions on global movement, if prolonged, could disrupt production, sales and product development across the industry.
The South Korean chipmaker, which counts Apple Inc (NASDAQ: AAPL) among its customers, posted a 41% drop in quarterly profit, but beat estimates by a large margin as server demand due to the coronavirus-driven shift to working from home partly offset weak smartphone business.
SK Hynix reported an operating profit of 800... More
Pre-Open Stock Movers 04/22: (IMUX) (SNAP) (CMG) Higher; (VBIV) (IBKR) (BIIB) Lower (more...)
April 22, 2020 9:05 AM EDTToday's Pre-Open Stock Movers:
Immunic, Inc. (Nasdaq: IMUX) 62.3% HIGHER; reported that its lead asset, IMU-838, a selective oral DHODH inhibitor, has successfully demonstrated preclinical activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). More specifically, IMU-838 was observed to inhibit replication of clinical isolates of SARS-CoV-2 associated with coronavirus disease 2019 (COVID-19). In cellular assays, IMU-838 demonstrated this antiviral activity at concentrations which are well below the blood concentrations associated with IMU-838 dosing regimens studied in ongoing and previous clinical trials. These positive results have encouraged Immunic to... More
Texas Instruments (TXN) PT Lowered to $120 at Oppenheimer
April 22, 2020 8:46 AM EDTOppenheimer analyst Rick Schafer lowered the price target on Texas Instruments (NASDAQ: TXN) to $120.00 (from $140.00) while maintaining a Outperform rating.... More
Texas Instruments (TXN) PT Lowered to $94 at Morgan Stanley
April 22, 2020 7:52 AM EDTMorgan Stanley analyst Joseph Moore lowered the price target on Texas Instruments (NASDAQ: TXN) to $94.00 (from $101.00) while maintaining a Underweight rating.... More
Texas Instruments (TXN) Sandbagged Guidance, PT Lowered to $135 at Rosenblatt
April 22, 2020 7:33 AM EDTRosenblatt analyst Hans Mosesmann lowered the price target on Texas Instruments (NASDAQ: TXN) to $135.00 (from $150.00) after the company offered a 2Q20 guide including an assumed recessionary 2020 that seems to provide the street with a worst case scenario.
The analyst is more optimistic, reiterating... More
Texas Instruments (TXN) PT Raised to $114 at SunTrust
April 22, 2020 7:33 AM EDTSunTrust raised its price target on Texas Instruments (NASDAQ: TXN) to $114.00 (from $109.00) while maintaining a Hold rating.... More
Texas Instruments (TXN) PT Lowered to $111 at Mizuho Securities
April 22, 2020 6:47 AM EDTMizuho Securities analyst Vijay Rakesh lowered the price target on Texas Instruments (NASDAQ: TXN) to $111.00 (from $112.00) while maintaining a Neutral rating. TXN reported March quarter revenues and EPS of $3.3B/$1.24 (above consensus $3.1B/$1.01). TXN guided June quarter Revenues and EPS to $2.9B/~$0.84 (down... More
Texas Instruments (TXN) PT Lowered to $125 at RBC Capital
April 22, 2020 6:41 AM EDTRBC Capital analyst Mitch Steves lowered the price target on Texas Instruments (NASDAQ: TXN) to $125.00 (from $135.00) while maintaining a Sector Perform rating.... More
Texas Instruments (TXN) PT Raised to $111 at UBS
April 22, 2020 6:05 AM EDTUBS analyst Timothy Arcuri raised the price target on Texas Instruments (NASDAQ: TXN) to $111.00 (from $109.00) while maintaining a Neutral rating.... More
Loop Capital Downgrades Texas Instruments (TXN) to Hold
April 22, 2020 5:10 AM EDTLoop Capital downgraded Texas Instruments (NASDAQ: TXN) from Buy to Hold.
For an analyst ratings summary and ratings history on Texas Instruments click here. For more ratings news on Texas Instruments click here.
Shares of Texas Instruments closed at $106.84 yesterday.
... MoreLongbow Research Reinstates Texas Instruments (TXN) at Neutral
April 22, 2020 4:50 AM EDTLongbow Research analyst Nikolay Todorov reinstates coverage on Texas Instruments (NASDAQ: TXN) with a Neutral rating.
For an analyst ratings summary and ratings history on Texas Instruments click here. For more ratings news on Texas Instruments click here.
Shares of Texas Instruments closed at $106.84 yesterday.
... MoreAfter-Hours Stock Movers 04/21: (IMUX) (SNAP) (USNA) Higher; (VBIV) (IBKR) (UAL) Lower (more...)
April 21, 2020 6:17 PM EDTToday's After-Hours Stock Movers:
Immunic, Inc. (Nasdaq: IMUX) 62.3% HIGHER; reported that its lead asset, IMU-838, a selective oral DHODH inhibitor, has successfully demonstrated preclinical activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). More specifically, IMU-838 was observed to inhibit replication of clinical isolates of SARS-CoV-2 associated with coronavirus disease 2019 (COVID-19). In cellular assays, IMU-838 demonstrated this antiviral activity at concentrations which are well below the blood concentrations associated with IMU-838 dosing regimens studied in ongoing and previous clinical trials. These positive results have encouraged Immunic to prepare a... More
Texas Instruments prepares for coronavirus crisis after strong first quarter
April 21, 2020 4:24 PM EDTBy Munsif Vengattil and Stephen Nellis
(Reuters) - Texas Instruments Inc (NASDAQ: TXN) on Tuesday reported better-than-expected results for the first quarter but forecast current-quarter revenue and profit largely below Wall Street estimates, as the chip industry braces for a big hit from the coronavirus outbreak.
As TI supplies chips for everything from smart phones to automobiles and often reports earnings before other chipmakers, investors watch its results closely as a proxy for both the health of the chip industry and other sectors where semiconductors are key components.
Despite the... More
Texas Instruments (TXN) Q1 Revenue Beats, Offers Q2 Guidance
April 21, 2020 4:03 PM EDTTexas Instruments (NASDAQ: TXN) reported Q1 EPS of $1.24, may not compare to the analyst estimate of $1.00. Revenue for the quarter came in at $3.33 billion versus the consensus estimate of $3.17 billion.
Earnings per share include a 10-cent benefit for items that were not in the... MoreWall Street tumbles as oil crash stirs pandemic fears
April 21, 2020 6:35 AM EDTBy Noel Randewich
(Reuters) - Wall Street tumbled for a second straight day on Tuesday as a collapse in U.S. oil prices and glum forecasts by companies worsened fears of a deep economic downturn.
All 11 S&P 500 sector indexes fell 1.6% or more, with energy sliding for the seventh time in eight sessions a day after the WTI contract crashed below zero as oil traders ran out of storage for May deliveries.
With the collapse spilling into June futures contracts, equity investors became wary of the extent of the economic damage from sweeping lockdown... More

